6-methyl-3-(3-methyl-1,2-oxazol-5-yl)quinazolin-4-one

Names

[ CAS No. ]:
144485-86-9

[ Name ]:
6-methyl-3-(3-methyl-1,2-oxazol-5-yl)quinazolin-4-one

Chemical & Physical Properties

[ Density]:
1.35g/cm3

[ Boiling Point ]:
471.4ºC at 760 mmHg

[ Molecular Formula ]:
C13H11N3O2

[ Molecular Weight ]:
241.24500

[ Flash Point ]:
238.9ºC

[ Exact Mass ]:
241.08500

[ PSA ]:
60.92000

[ LogP ]:
1.99050

[ Vapour Pressure ]:
4.66E-09mmHg at 25°C

[ Index of Refraction ]:
1.67

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VA3679020
CHEMICAL NAME :
4(3H)-Quinazolinone, 6-methyl-3-(3-methyl-5-isoxazolyl)-
CAS REGISTRY NUMBER :
144485-86-9
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C13-H11-N3-O2
MOLECULAR WEIGHT :
241.27

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
FRMCE8 Farmaco. (Societa Chimica Italiana, Corso Strada Nova, 86, Casella Postale 227, 27100 Pavia, Italy) V.44- 1989- Volume(issue)/page/year: 47,465,1992
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
FRMCE8 Farmaco. (Societa Chimica Italiana, Corso Strada Nova, 86, Casella Postale 227, 27100 Pavia, Italy) V.44- 1989- Volume(issue)/page/year: 47,465,1992

Synthetic Route

Precursor & DownStream

Precursor

  • 5-methyl-2-nitrobenzoyl chloride
  • 5-methyl-N-(3-methylisoxazol-5-yl)-2-nitrobenzamide

DownStream


Related Compounds

  • 2-(4-Methoxy-2-propan-2-yloxyanilino)-7-phenylthieno[3,2-d]pyrimidine-6-carboxamide
  • N-(6-methoxy-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-1-methyl-1H-indole-4-carboxamide
  • N-(6-methoxy-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-[(4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy]acetamide
  • N-(5-(ethylthio)-1,3,4-thiadiazol-2-yl)-2-(3-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)azetidin-1-yl)acetamide oxalate
  • N-(6-methoxy-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-(1-methyl-1H-indol-3-yl)butanamide
  • 3-(Thiophen-2-yl)-5-(1-(3-(trifluoromethyl)benzyl)azetidin-3-yl)-1,2,4-oxadiazole oxalate
  • (2R)-2-[(2-chloropyridin-3-yl)formamido]-3-(1H-indol-3-yl)propanoic acid
  • 5-(1-(3-Chlorobenzyl)azetidin-3-yl)-3-(thiophen-2-yl)-1,2,4-oxadiazole oxalate
  • 3-(4-methoxyphenyl)-N-[4-oxo-3-(propan-2-yl)-3,4-dihydroquinazolin-6-yl]propanamide
  • 5-(1-(Pyridin-2-ylmethyl)azetidin-3-yl)-3-(thiophen-2-yl)-1,2,4-oxadiazole oxalate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.